5-112842348-C-G

Variant names:

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_000038.6(APC):c.6754C>G(p.Pro2252Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P2252L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)

Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

APC
NM_000038.6 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2O:1

Conservation

PhyloP100: 2.67

Publications

3 publications found

Variant links:

Genes affected

APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]

APC Gene-Disease associations (from GenCC):

classic or attenuated familial adenomatous polyposis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
desmoid tumor
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
familial adenomatous polyposis 1
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
gastric adenocarcinoma and proximal polyposis of the stomach
Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
sarcoma
Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
APC-related attenuated familial adenomatous polyposis
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Turcot syndrome with polyposis
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Cenani-Lenz syndactyly syndrome
Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

APC links:

ENSG00000258864 (HGNC:):

ENSG00000258864 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2

Very rare variant in population databases, with high coverage;

BP4

Computational evidence support a benign effect (MetaRNN=0.23401773).

BP6

Variant 5-112842348-C-G is Benign according to our data. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520. Variant chr5-112842348-C-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 133520.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
APC	NM_000038.6 link	c.6754C>G	p.Pro2252Ala	missense_variant	Exon 16 of 16	ENST00000257430.9	NP_000029.2	P25054-1Q4LE70

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
APC	ENST00000257430.9 link	c.6754C>G	p.Pro2252Ala	missense_variant	Exon 16 of 16	5	NM_000038.6	ENSP00000257430.4		P25054-1
ENSG00000258864	ENST00000520401.1 link	n.228+13376C>G		intron_variant	Intron 3 of 7	3		ENSP00000454861.1		H3BNH8

Frequencies

GnomAD3 genomes

Cov.:

GnomAD2 exomes

AF:

0.00000797

AC:

AN:

250950

AF XY:

0.00000737

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.000109

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.00000137

AC:

AN:

1461724

Hom.:

Cov.:

AF XY:

0.00000138

AC XY:

AN XY:

727152

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33470

American (AMR)

AF:

0.00

AC:

AN:

44712

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26132

East Asian (EAS)

AF:

0.0000504

AC:

AN:

39698

South Asian (SAS)

AF:

0.00

AC:

AN:

86252

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53410

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

1111888

Other (OTH)

AF:

0.00

AC:

AN:

60394

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.525

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

Cov.:

ExAC

AF:

0.00000824

AC:

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:2Benign:2Other:1

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

not specified

Uncertain:1Benign:1Other:1

Apr 23, 2024

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

Variant summary: APC c.6754C>G (p.Pro2252Ala) results in a non-conservative amino acid change located in the Adenomatous polyposis coli protein basic domain (IPR009234) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250950 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.6754C>G has been reported in the literature in individuals affected with primary hyperparathyroidism and Biliary tract cancer, without strong evidence for causality (example, Okawa_2023, Park_2022). These report(s) do not provide unequivocal conclusions about association of the variant with Colorectal Cancer Risk. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36243179, 35586626). ClinVar contains an entry for this variant (Variation ID: 133520). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Mar 04, 2025

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Sep 19, 2013

ITMI

Significance:not provided

Review Status:no classification provided

Collection Method:reference population

- -

Familial adenomatous polyposis 1

Uncertain:1

Jan 14, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 2252 of the APC protein (p.Pro2252Ala). This variant is present in population databases (rs587778035, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 133520). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt APC protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Hereditary cancer-predisposing syndrome

Benign:1

Jan 31, 2025

Ambry Genetics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.054

BayesDel_addAF

Benign

-0.14

BayesDel_noAF

Benign

-0.21

CADD

Benign

(source)

DANN

Benign

0.94

DEOGEN2

Benign

0.35

T;T

Eigen

Benign

-0.23

Eigen_PC

Benign

-0.13

FATHMM_MKL

Benign

0.37

LIST_S2

Uncertain

0.93

.;D

M_CAP

Benign

0.046

MetaRNN

Benign

0.23

T;T

MetaSVM

Benign

-0.39

MutationAssessor

Benign

1.1

L;L

PhyloP100

2.7

PrimateAI

Benign

0.43

PROVEAN

Benign

-1.4

N;N

REVEL

Benign

0.27

Sift

Benign

0.054

T;T

Sift4G

Benign

0.11

T;T

Polyphen

0.090

B;B

Vest4

0.33

MutPred

0.48

Loss of glycosylation at P2252 (P = 0.0153);Loss of glycosylation at P2252 (P = 0.0153);

MVP

0.86

ClinPred

0.087

GERP RS

4.0

Varity_R

0.028

gMVP

0.35

Mutation Taster

=54/46

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over